Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • carpenoctem
    Junior Member
    • May 2011
    • 1

    #1

    A couple questions on RNA-seq

    Hi guys, I'm trying to use RNA-seq to identify RNA editing sites in mouse. I'm a summer student, so I don't really have any experience with RNA-seq and I've run into a couple of things that have confused me so far. I'm mostly following the methods used in these papers: http://www.nature.com/ng/journal/v43...ll/ng.872.html http://www.sciencemag.org/content/ea...07018.abstract. I'm using 42 bp single end reads from Illumina, and I aligned to the RefSeq known genes, omitting introns, with Novoalign.

    1) What quality score do people tend to use as a cutoff when trimming reads? I trimmed the reads 5' and 3' to a quality score of 30, and then threw out reads with length less than 35, but I noticed that I lost a lot of reads by doing this. How beneficial is trimming reads?

    2) When visualizing my data with Tablet, I noticed that there were some regions where it seemed like all the reads that aligned were from one strand only. Is there any reason why this would be the case? Our library prep was not strand-specific, so I would expect a fairly even split between each strand (which I do see for the most part).

    3) Does anybody know of software/papers that look at probabilities for RNA-editing? Currently I'm just picking out any bases where 10% of the reads differ, which seems rather unscientific.

    4) After identifying possible RNA editing sites, I noticed that rather than A-to-G editing being most prevalent, as I would expect, it seems that each type of conversion is equally prevalent. Does anybody have an idea why this might be? Something with the library prep maybe?

    Thanks for any help you can provide.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...